Carolyn Compton, Caren Mason

Dec 10, 2014

HealthTell said this week that Carolyn Compton and Caren Mason have joined the company's board of directors.

Compton is chief medical officer of the National Biomarkers Development Alliance at Arizona State Universitywhere she is also a professor of life sciences.

Mason was formerly CEO of Verinata Health, which was acquired by Illumina in 2013. Before that she was CEO of Quidel.

Breaking News

People in the News at Danaher, QuidelOrtho, Myriad Genetics, Hologic, Pacific Biosciences, More
New Products Posted to GenomeWeb: Qiagen, Parse Biosciences, Bio-Techne
T2 Biosystems Receives Delisting Notice From Nasdaq
In Brief This Week: Inocras, Sysmex Inostics, Danaher, Abbott, Genesupport, GeninCode, More
Roche Receives CE Mark for Updated High-Throughput Cobas Platform

Carolyn Compton, Caren Mason

People in the News at Danaher, QuidelOrtho, Myriad Genetics, Hologic, Pacific Biosciences, More

New Products Posted to GenomeWeb: Qiagen, Parse Biosciences, Bio-Techne

T2 Biosystems Receives Delisting Notice From Nasdaq

In Brief This Week: Inocras, Sysmex Inostics, Danaher, Abbott, Genesupport, GeninCode, More

Roche Receives CE Mark for Updated High-Throughput Cobas Platform